94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Glob. Womens Health
Sec. Women's Mental Health
Volume 6 - 2025 | doi: 10.3389/fgwh.2025.1520641
This article is part of the Research Topic Bridging the Knowledge Gap: Mental Health, Substance Use Disorders, and Mortality in Women View all 3 articles
Analysis of risk factors for depression and anxiety in women with polycystic ovary syndrome
Provisionally accepted- 1 Lanzhou University, Lanzhou, Gansu Province, China
- 2 Lanzhou University Second Hospital, Lanzhou, China
Background: Polycystic ovary syndrome (PCOS) is one of the most common reproductive endocrine disorders among women of reproductive age, often accompanied by a series of symptoms such as hirsutism, hair loss, menstrual disorders and obesity, resulting in an increasing risk of depression and anxiety in such patients.Methods: A total of 413 patients in the Reproductive Medicine Center of the Second Hospital of Lanzhou University from June 2021 to June 2023 were enrolled. We collected sociodemographic information and lifestyle-related factors using a structured questionnaire. Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder Scale (GAD-7) were used to evaluate the psychological status of the subjects.Sleep-related variables were assessed using the Pittsburgh Sleep Quality Index (PSQI), and metabolic measures were collected from patients' medical records.Results: Compared with the control group, PCOS patients were younger, the average age was (27.39 3.48) years old, and the BMI value was higher, the difference was statistically significant (p< 0.05). The proportions of depression and anxiety in PCOS patients were 47.7% and 39.9%, respectively. In PCOS patients with depressive anxiety symptoms, the proportions of mild, moderate, moderately severe and severe depression were 31.6%, 12.4%, 1.6% and 2.1%, respectively. The proportions of mild, moderate, moderately severe and severe anxiety were 30.6%, 6.2%, 1.0% and 2.1%, respectively. Depression was significantly associated with serum free triiodothyronine (FT3) OR (95%CI) =3.33 (1.30-8.55), sleep duration 4.99 (1.45-17.23) and daytime dysfunction 8. 24 (3.53-19.22). Anxiety was significantly associated with daytime dysfunction OR (95%CI) =3.45 (1.78-6.70). No association was found between mental health and other metabolic characteristics in PCOS patients(p 0.05).According to the results of the current study, a high proportion of women with PCOS have mental health disorders, and there is a significant correlation between mental health disorders and sleep conditions.
Keywords: Polycystic Ovary Syndrome, Depression, Anxiety, Sleep Disorders, Mental Health
Received: 31 Oct 2024; Accepted: 13 Feb 2025.
Copyright: © 2025 Yang, Liu, Hu, Huyan, Yang and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Fang Wang, Lanzhou University Second Hospital, Lanzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.